Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 300.5234
- Book/Share 61.1499
- PB 1.0291
- Debt/Equity 1.0557
- CurrentRatio 0.8227
- ROIC 0.0403
- MktCap 79417955600.0
- FreeCF/Share 4.7113
- PFCF 13.3678
- PE 14.9935
- Debt/Assets 0.3178
- DivYield 0.0424
- ROE 0.0698
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS Sues Arkansas Over Law Banning PBM Ownership Of Pharmacies
Published: May 29, 2025 by: Forbes
Sentiment: Negative
CVS Health Thursday sued the state of Arkansas, trying to thwart a law the healthcare company said would lead to the closure of all 23 CVS drugstores in the state.
Read More
5 Valuable Price-to-Book Stocks to Strengthen Your Portfolio
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and PSFE are some such stocks.
Read More
CVS or DHR: Which Is the Better Value Stock Right Now?
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
Avoid These Dividend Disasters Before It's Too Late
Published: May 23, 2025 by: Seeking Alpha
Sentiment: Negative
Dividend stocks are facing many big risks. The high interest rates, trade war, and AI revolution could lead to many dividend cuts. I discuss what this all means for dividend investors.
Read More
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
UnitedHealth, CVS Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Published: May 22, 2025 by: Benzinga
Sentiment: Negative
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday.
Read More
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
2 Dividend Stocks That are Holding Their Own in 2025
Published: May 17, 2025 by: 24/7 Wall Street
Sentiment: Positive
Perhaps it's not all too surprising to witness the S&P 500 run into turbulence after two of the best years for stock gains in recent memory.
Read More
Here's Why CVS Health (CVS) Looks Ripe for Bottom Fishing
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health (CVS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
CVS bids for Rite Aid stores, Bloomberg News reports
Published: May 15, 2025 by: Reuters
Sentiment: Positive
Healthcare conglomerate CVS Health has bid for a significant number of stores and patient data from bankrupt pharmacy chain operator Rite Aid, Bloomberg News reported on Thursday.
Read More
UNH Stock Vs. CVS Stock
Published: May 15, 2025 by: Forbes
Sentiment: Negative
Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs. This comes during a challenging time when the CEO Andrew Witty also stepped down for ‘personal reasons.
Read More
5 Low Price-to-Book Value Stocks to Buy in May
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.
Read More
4 Value Picks to Ride the Market Rebound After US-China Trade Thaw
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. STNE, CNC, CVS & PFE boast a low P/CF ratio.
Read More
CVS Health celebrates reopening of Hendersonville store destroyed by Hurricane Helene
Published: May 12, 2025 by: PRNewsWire
Sentiment: Neutral
The South Main Street CVS Pharmacy is again providing health, wellness and pharmacy services to customers and patients WOONSOCKET, R.I. , May 12, 2025 /PRNewswire/ -- Today, leaders from CVS Health® (NYSE: CVS) were joined by state and local representatives to celebrate the reopening of one of its Hendersonville CVS Pharmacy stores.
Read More
Levi & Korsinsky Investigates Possible Securities Fraud Violations by CVS Health Corporation (CVS)
Published: May 12, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.
Read More
CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced
Published: May 11, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health has shown impressive year-to-date performance, driven by strong Q1 results and strategic shifts in its business model. I reiterate a buy rating on CVS due to its low valuation, mixed technicals, and promising earnings growth prospects. Key catalysts include improved performance in Healthcare Benefits, higher star ratings in Medicare Advantage, and strategic exits from less profitable areas.
Read More
CVS vs. DHR: Which Stock Is the Better Value Option?
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical Services sector might want to consider either CVS Health (CVS) or Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
ATTENTION CVS SHAREHOLDERS: Investors Who Lost Money on CVS Health Corporation Are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
Published: May 08, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.
Read More
GLP-1 competition heats up: Novo Nordisk CEO talks Wegovy, CVS deal, earnings
Published: May 07, 2025 by: Yahoo Finance
Sentiment: Positive
Pharmaceutical company Novo Nordisk (NVO) came out swinging Wednesday morning as the stock initially jumped on its first quarter earnings beat ($0.99 per share vs. estimates of $0.94).
Read More
Healthy Returns: Novo Nordisk's Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Published: May 07, 2025 by: CNBC
Sentiment: Neutral
Eli Lilly won't lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.
Read More
Kirby McInerney LLP Announces Investigation of Claims Against CVS Health Corporation (CVS) on Behalf of Investors
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against CVS Health Corporation (“CVS” or the “Company”) (NYSE:CVS). The investigation concerns whether CVS and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
Read More
Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Positive
In this article, I present 10 attractive high-yield investment options for this month of May 2025, which not only offer dividend income but also potential for dividend growth. The selection process involves analyzing financial ratios, competitive advantages, valuations, and diversification across industries and countries to minimize risks and maximize returns. Highlighted top picks for May 2025 include VICI Properties, Chevron, Canadian Natural Resources, Pfizer, Altria, CVS Health, Toronto-Dominion Bank, Comcast, Vale, and Ares Capital.
Read More
What Makes CVS Health (CVS) a New Buy Stock
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
Published: May 01, 2025 by: Benzinga
Sentiment: Positive
Novo Nordisk A/S NVO announced that CVS Health Inc's CVS CVS Caremark, a Pharmacy Benefit Manager (PBM), has decided that Wegovy (semaglutide) injection 2.4 mg will soon be the preferred GLP-1 medicine on its largest commercial template formularies.
Read More
CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone
Published: May 01, 2025 by: Seeking Alpha
Sentiment: Negative
Eli Lilly and Company's stock fell over 11% after CVS Caremark excluded Lilly's obesity drug Zepbound from its standard commercial formularies starting July 1, 2025. The market overreacted to CVS's exclusion, creating a temporary mispricing in Lilly's stock, presenting a potential buying opportunity. Despite CVS's exclusion, Zepbound still has broad market access through other PBMs and regional health plans, ensuring continued sales growth.
Read More
CVS earnings: Things are finally clicking for the healthcare giant
Published: May 01, 2025 by: Yahoo Finance
Sentiment: Positive
CVS (CVS) stock jumped after beating first quarter earnings and revenue expectations. Jefferies Healthcare Services equity research analyst Brian Tanquilut explains how CVS's margin recovery and business diversification signal growing investor confidence.
Read More
Initial Claims More Than Expectations
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
Initial Claims More Than Expectations.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO Mr. J. David Joyner CEBS
- Employees 219000